Twist Bioscience Corp reports $59.2 million Q2 profit

Twist Bioscience Corp [TWST] has reported fiscal Q2 profit of $59.20 million.

On a per-share basis, the DE based company said its diluted earnings are $1.04.

The Biological Products, Except Diagnostic Substances firm posted revenue of $60.20 million in this period.

Also Read:

• Twist Bioscience Reports Fiscal Second Quarter 2023 Financial Results
• Twist Bioscience and Aster Insights Partner on Launch of Next Generation Oncology Panel for Cancer Research
• Twist Bioscience Launches TCR and CAR Libraries to Enable the Development of Cell Therapies
• Twist Bioscience to Report Fiscal 2023 Second Quarter Financial Results on Friday, May 5, 2023
• Twist Bioscience Announces Robust Antibody Discovery Services Integrating In Vivo, In Vitro and In Silico Approaches